Nevertheless, interleukin-8, also known as CXCL8, binds to the receptors CXCR1 and CXCR2 has been shown to mediate tumour progression, epithelial-mesenchymal transition, invasion, and angiogenesis. This evidence concerns the gene CXCR2 and neoplasm.